Combined administration hemolytic anemia

Southeast University in Nanjing subsidiary Zhongshan University Hospital's blood tumor specialist Dr. Bao in Nanjing introduced for the first time plasma exchange, splenectomy and drug treatment for a comprehensive approach to the treatment of refractory anemia success, the first critical patients have resumed very good. Refractory hemolytic anemia is a lower incidence of blood diseases, the plasma of patients have abnormal antibodies, disruption of normal red blood cell function and trigger jaundice, anemia, kidney function and other symptoms of depression, serious life-threatening. Most of the past using drug therapy, but the disease control is not satisfactory, but larger drug side effects. Southeast University, Zhongshan University Hospital subsidiary blood oncology adopt the most advanced plasma exchange technology, the blood of the patients with abnormal antibodies through blood cell separator to isolate, and then return into the patient's body by several replacement, the patient's abnormal plasma antibody successfully been eliminated. While the patient's body to destroy red blood cells to provide the venue for the removal of the spleen. A 48-year-old patients at the Shanghai, Jiangsu and other treatment to the hospital several times, but little improvement has anemia, came to the hospitals visited, indirect bilirubin found more than 10 times higher than normal, the hospital experts used combination therapy for a successful treatment, clinical observation confirmed that the patients will be radical and resume a normal life.